Author:
Jorge Toquero Ramos,Alejandro Durante-López,Jesús González Mirelis,Víctor Castro Urda,Eusebio García Izquierdo,Diego Jiménez Sánchez,Ignacio Fernández-Lozano
Publisher
Heighten Science Publications Corporation
Reference20 articles.
1. 1. Stewart S, Hart CL, Hole DJ, McMurray JJ. A Population-Based Study of the Long-Term Risks Associated with Atrial Fibrillation: 20-Year Follow-up of the Renfrew/Paisley Study. Am J Med. 2002: 113: 359-364. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/12401529
2. 2. Lafuente-Lafuente C1, Valembois L, Bergmann JF, Belmin J. Antiarrhythmics for Maintaining Sinus Rhythm after Cardioversion of Atrial Fibrillation. Cochrane Database Syst Rev. 2015; CD005049. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25820938
3. 3. Kirchhof P Benussi S1, Kotecha D, Ahlsson A, Atar D, et al. 2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration with EACTS. Eur Heart J. 2016; 50:, e1-e88. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27663299
4. 4. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, et al. 2014 AHA/ACC/HRS Guideline for the Management of Patients with Atrial Fibrillation: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014; 64: e1-76. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24685669
5. 5. Squara F, Zhao A, Marijon E, Latcu DG4 Providencia R, et al. Comparison between Radiofrequency with Contact Force-Sensing and Second-Generation Cryoballoon for Paroxysmal Atrial Fibrillation Catheter Ablation: A Multicentre European Evaluation. Europace. 2015; 17: 718-724. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25840289